Detalhe da pesquisa
1.
Treatment and Epidemiology of Third-Generation Cephalosporin-Resistant Urinary Tract Infections.
Pediatrics
; 150(1)2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734948
2.
The Bordetella type III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts.
Cell Microbiol
; 11(12): 1735-49, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19650828
3.
Profile of the Pediatric Infectious Disease Workforce in 2015.
J Pediatric Infect Dis Soc
; 8(1): 29-38, 2019 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29309614
4.
Update on adolescent immunization: pertussis, meningococcus, HPV, and the future.
Cleve Clin J Med
; 74(10): 714-6, 719-27, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17941292
5.
Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults?
Drugs
; 66(6): 731-41, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16706548
6.
Is Acute Solid Food Aversion a Proxy for COVID-19-Related Olfactory and Gustatory Dysfunction?
Pediatrics
; 2021 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34814189
7.
Is Acute Solid Food Aversion a Proxy for COVID-19-Related Olfactory and Gustatory Dysfunction?
Pediatrics
; 2021 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34654753
8.
Pertussis: persistent pathogen, imperfect vaccines.
Expert Rev Vaccines
; 2(1): 113-27, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12901603
9.
Clinical evaluation of a DTaP-HepB-IPV combined vaccine.
Am J Manag Care
; 9(1 Suppl): S13-22, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12564785
10.
Cost-benefit analysis of hospital based postpartum vaccination with combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap).
Vaccine
; 31(22): 2558-64, 2013 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23583811
11.
Cost-benefit analysis of in-hospital influenza vaccination of postpartum women.
Obstet Gynecol
; 119(2 Pt 1): 306-14, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22270282
12.
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccine.
Pediatr Infect Dis J
; 30(12): 1086-91, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21983216
13.
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers.
Pediatrics
; 126(3): e493-505, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20732948
14.
Paralytic syndromes in children: epidemiology and relationship to vaccination.
Pediatr Neurol
; 42(3): 206-12, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20159431
15.
PEDIARIX: clinical trials.
Expert Rev Vaccines
; 4(2): 139-45, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15889985
16.
A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy.
J Infect Dis
; 191(7): 1116-22, 2005 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15747247
17.
Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants.
Vaccine
; 21(19-20): 2627-31, 2003 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-12744899